199 related articles for article (PubMed ID: 35941154)
21. A Noncanonical Autophagy Pathway Restricts Toxoplasma gondii Growth in a Strain-Specific Manner in IFN-γ-Activated Human Cells.
Selleck EM; Orchard RC; Lassen KG; Beatty WL; Xavier RJ; Levine B; Virgin HW; Sibley LD
mBio; 2015 Sep; 6(5):e01157-15. PubMed ID: 26350966
[TBL] [Abstract][Full Text] [Related]
22. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.
Martens S; Parvanova I; Zerrahn J; Griffiths G; Schell G; Reichmann G; Howard JC
PLoS Pathog; 2005 Nov; 1(3):e24. PubMed ID: 16304607
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Control of IFN-γ Host Responses During Infection With
Nast R; Choepak T; Lüder CGK
Front Immunol; 2020; 11():581241. PubMed ID: 33072127
[TBL] [Abstract][Full Text] [Related]
24. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-gamma.
Subauste CS; Wessendarp M
J Immunol; 2000 Aug; 165(3):1498-505. PubMed ID: 10903756
[TBL] [Abstract][Full Text] [Related]
25. Toxoplasma gondii GRA60 is an effector protein that modulates host cell autonomous immunity and contributes to virulence.
Nyonda MA; Hammoudi PM; Ye S; Maire J; Marq JB; Yamamoto M; Soldati-Favre D
Cell Microbiol; 2021 Feb; 23(2):e13278. PubMed ID: 33040458
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma.
Nishikawa Y; Xuenan X; Makala L; Vielemeyer O; Joiner KA; Nagasawa H
Int J Parasitol; 2003 Nov; 33(13):1525-35. PubMed ID: 14572515
[TBL] [Abstract][Full Text] [Related]
27. Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes.
Halonen SK; Weiss LM
Infect Immun; 2000 Jun; 68(6):3426-30. PubMed ID: 10816494
[TBL] [Abstract][Full Text] [Related]
28. Neuronal impairment following chronic Toxoplasma gondii infection is aggravated by intestinal nematode challenge in an IFN-γ-dependent manner.
French T; Düsedau HP; Steffen J; Biswas A; Ahmed N; Hartmann S; Schüler T; Schott BH; Dunay IR
J Neuroinflammation; 2019 Jul; 16(1):159. PubMed ID: 31352901
[TBL] [Abstract][Full Text] [Related]
29. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression.
Lang C; Algner M; Beinert N; Gross U; Lüder CG
Microbes Infect; 2006 Jul; 8(8):1994-2005. PubMed ID: 16824778
[TBL] [Abstract][Full Text] [Related]
30. IFN-γ-mediated neuronal defense mechanism targets Toxoplasma.
Figueiredo CA; Dunay IR
Trends Parasitol; 2022 Dec; 38(12):1023-1025. PubMed ID: 36280528
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
32. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it.
Virreira Winter S; Niedelman W; Jensen KD; Rosowski EE; Julien L; Spooner E; Caradonna K; Burleigh BA; Saeij JP; Ploegh HL; Frickel EM
PLoS One; 2011; 6(9):e24434. PubMed ID: 21931713
[TBL] [Abstract][Full Text] [Related]
33. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii.
Schlüter D; Deckert M; Hof H; Frei K
Infect Immun; 2001 Dec; 69(12):7889-93. PubMed ID: 11705972
[TBL] [Abstract][Full Text] [Related]
34. The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments.
Collazo CM; Yap GS; Hieny S; Caspar P; Feng CG; Taylor GA; Sher A
Infect Immun; 2002 Dec; 70(12):6933-9. PubMed ID: 12438372
[TBL] [Abstract][Full Text] [Related]
35. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling.
Zimmermann S; Murray PJ; Heeg K; Dalpke AH
J Immunol; 2006 Feb; 176(3):1840-7. PubMed ID: 16424215
[TBL] [Abstract][Full Text] [Related]
36. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
37. ROP39 is an Irgb10-specific parasite effector that modulates acute Toxoplasma gondii virulence.
Singh S; Murillo-León M; Endres NS; Arenas Soto AF; Gómez-Marín JE; Melbert F; Kanneganti TD; Yamamoto M; Campos C; Howard JC; Taylor GA; Steinfeldt T
PLoS Pathog; 2023 Jan; 19(1):e1011003. PubMed ID: 36603017
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.
Rozenfeld C; Martinez R; Seabra S; Sant'anna C; Gonçalves JG; Bozza M; Moura-Neto V; De Souza W
Am J Pathol; 2005 Oct; 167(4):1021-31. PubMed ID: 16192637
[TBL] [Abstract][Full Text] [Related]
39. The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens.
Liesenfeld O; Parvanova I; Zerrahn J; Han SJ; Heinrich F; Muñoz M; Kaiser F; Aebischer T; Buch T; Waisman A; Reichmann G; Utermöhlen O; von Stebut E; von Loewenich FD; Bogdan C; Specht S; Saeftel M; Hoerauf A; Mota MM; Könen-Waisman S; Kaufmann SH; Howard JC
PLoS One; 2011; 6(6):e20568. PubMed ID: 21698150
[TBL] [Abstract][Full Text] [Related]
40. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.
Lüder CG; Giraldo-Velásquez M; Sendtner M; Gross U
Exp Parasitol; 1999 Sep; 93(1):23-32. PubMed ID: 10464035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
